Die Dynamik im Q3/FY 24-25 (FY 25) war spürbar geringer als in den Quartalen zuvor. Der Konzernumsatz stieg nach vorläufigen KPIs (in CC) um 3 % YoY auf € 256 Mio. Jüngst waren Marktverunsicherungen spürbar. Anhaltend starke Nachfrage nach „High Value Solutions“ (HVS-Anteil/Konzernumsatz: 60 %) erzeugte einen positiven Produktmixeffekt, der margenrelevant (vor ramp-up-Kosten (FY 25: € 10-15 Mio.)) ist. Das adj. EBITDA stieg auf € 83 Mio. (in CC.: +11 %; Marge 32,4 %; Vj: 29,4 %). In der Konseq...
The dynamics in Q3/FY 24-25 were noticeably lower than in the previous quarters. The group revenue increased by 3% YoY to € 256m based on preliminary KPIs (in CC). Recently, market uncertainties were palpable. Sustained strong demand for 'High Value Solutions' (HVS share/group revenue: 60%) created a positive product mix effect, which is relevant for margins (before ramp-up costs (FY 25: € 10-15 million)). The adjusted EBITDA rose to € 83m (in CC: +11%; margin 32.4%; previous year: 29.4%). As a...
X-Fab presented a solid set of 2Q25 results and expect this positive trend to continue in 2H25. We saw an above-average order intake for X-Fab's microsystems business. With the completion of its CapEx program, X-Fab claims it is ideally positioned to grow profitably together with its customers (mainly Melexis). Sufficient capacity is now available for its most popular technologies, suited to address the megatrends of our time, such as the electrification of everything. This will generate high de...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.